Weekly paclitaxel plus ramucirumab versus weekly nab-paclitaxel plus ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to first-line therapy—the P-SELECT trial (WJOG10617G)—a randomised phase II trial by the West Japan Oncology Group

Kenro Hirata; Yasuo Hamamoto; Masahiko Ando; Chiyo K. Imamura; Kenichi Yoshimura; Kentaro Yamazaki; Shuichi Hironaka; Kei Muro

doi:10.1186/s12885-020-07047-1

Weekly paclitaxel plus ramucirumab versus weekly nab-paclitaxel plus ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to first-line therapy—the P-SELECT trial (WJOG10617G)—a randomised phase II trial by the West Japan Oncology Group

BMC Cancer ◽

10.1186/s12885-020-07047-1 ◽

2020 ◽

Vol 20 (1) ◽

Cited By ~ 1

Author(s):

Kenro Hirata ◽

Yasuo Hamamoto ◽

Masahiko Ando ◽

Chiyo K. Imamura ◽

Kenichi Yoshimura ◽

...

Keyword(s):

Gastric Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Peritoneal Dissemination ◽

Oncology Group ◽

First Line ◽

The West ◽

First Line Therapy ◽

Line Therapy ◽

Select Trial

Download Full-text

Randomized phase II trial of weekly paclitaxel + ramucirumab versus weekly nab-paclitaxel + ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to first-line therapy: WJOG10617G/P-SELECT

Annals of Oncology ◽

10.1093/annonc/mdz247.164 ◽

2019 ◽

Vol 30 ◽

pp. v323

Author(s):

K. Hirata ◽

Y. Hamamoto ◽

K. Tsuchihashi ◽

C. Kondoh ◽

K. Yamazaki ◽

...

Keyword(s):

Gastric Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Peritoneal Dissemination ◽

Weekly Paclitaxel ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Recurrent Gastric Cancer ◽

Randomized Phase Ii

Download Full-text

Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer

Annals of Oncology ◽

10.1093/annonc/mdr021 ◽

2011 ◽

Vol 22 (12) ◽

pp. 2610-2615 ◽

Cited By ~ 91

Author(s):

S. Iqbal ◽

B. Goldman ◽

C.M. Fenoglio-Preiser ◽

H.J. Lenz ◽

W. Zhang ◽

...

Keyword(s):

Gastric Cancer ◽

Phase Ii Trial ◽

Metastatic Gastric Cancer ◽

Oncology Group ◽

First Line ◽

Oncology Group Study ◽

Southwest Oncology Group ◽

First Line Therapy ◽

Line Therapy ◽

Southwest Oncology Group Study

Download Full-text

Re: Phase II Trial of Cisplatin, Gemcitabine, and Bevacizumab as First-Line Therapy for Metastatic Urothelial Carcinoma: Hoosier Oncology Group GU 04-75

The Journal of Urology ◽

10.1016/j.juro.2011.11.077 ◽

2012 ◽

Vol 187 (3) ◽

pp. 881-882

Author(s):

David P. Wood

Keyword(s):

Urothelial Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Oncology Group ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Metastatic Urothelial Carcinoma

Download Full-text

Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial

Annals of Oncology ◽

10.1093/annonc/mdm269 ◽

2007 ◽

Vol 18 (10) ◽

pp. 1673-1679 ◽

Cited By ~ 98

Author(s):

S. Lorenzen ◽

M. Hentrich ◽

C. Haberl ◽

V. Heinemann ◽

T. Schuster ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Gastroesophageal Junction ◽

First Line ◽

Split Dose ◽

First Line Therapy ◽

Line Therapy

Download Full-text

Phase II trial of capecitabine plus modified cisplatin (mXP) as first-line therapy in Japanese patients with metastatic gastric cancer (KSCC1104)

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-016-3204-6 ◽

2016 ◽

Vol 79 (1) ◽

pp. 147-153 ◽

Cited By ~ 2

Author(s):

Hironaga Satake ◽

◽

Masaaki Iwatsuki ◽

Yoshikazu Uenosono ◽

Takeshi Shiraishi ◽

...

Keyword(s):

Gastric Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Japanese Patients ◽

Metastatic Gastric Cancer ◽

First Line ◽

First Line Therapy ◽

Line Therapy

Download Full-text

Safety analysis of weekly paclitaxel plus S-1 versus paclitaxel plus 5-fluorouracil/calcium folinate as first-line therapy in advanced gastric cancer: a multicenter open random phase II trial

Journal of Chemotherapy ◽

10.1179/1973947812y.0000000057 ◽

2013 ◽

Vol 25 (1) ◽

pp. 56-59

Author(s):

Ting Deng ◽

Nong Xu ◽

Jian-Ping Xiong ◽

Zhao Yan ◽

Zhi-Xiang Zhuang ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Random Phase ◽

Calcium Folinate ◽

Weekly Paclitaxel ◽

First Line ◽

First Line Therapy ◽

Line Therapy

Download Full-text

Commentary on “Phase II trial of cisplatin, gemcitabine, and bevacizumab as first-line therapy for metastatic urothelial carcinoma: Hoosier Oncology Group GU 04–75.” Hahn NM, Stadler WM, Zon RT, Waterhouse D, Picus J, Nattam S, Johnson CS, Perkins SM, Waddell MJ, Sweeney CJ; Hoosier Oncology Group, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2011.11.019 ◽

2012 ◽

Vol 30 (2) ◽

pp. 228-229

Author(s):

H. Barton Grossman

Keyword(s):

Urothelial Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Cancer Center ◽

Oncology Group ◽

Indiana University ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Metastatic Urothelial Carcinoma

Download Full-text

Faculty Opinions recommendation of Phase II trial of cisplatin, gemcitabine, and bevacizumab as first-line therapy for metastatic urothelial carcinoma: Hoosier Oncology Group GU 04-75.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.11351956.12361054 ◽

2011 ◽

Author(s):

Thomas Flaig

Keyword(s):

Urothelial Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Oncology Group ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Metastatic Urothelial Carcinoma

Download Full-text

740 POSTER Fluorouracil, leucovorin and oxaliplatin (FLO) versus fluorouracil, leucovorin and cisplatin (FLP) as a first line therapy in patients with advanced gastric cancer —interim analysis of a multicenter, randomized phase II trial

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(05)81035-3 ◽

2005 ◽

Vol 3 (2) ◽

pp. 211-212

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Ii ◽

Interim Analysis ◽

Phase Ii Trial ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Randomized Phase Ii

Download Full-text

672 Randomised phase II trial (M77001) of trastuzumab (Herceptin®) plus docetaxel versus docetaxel alone, as first-line therapy in patients with HER2-positive metastitic breast cancer

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(03)90703-8 ◽

2003 ◽

Vol 1 (5) ◽

pp. S202 ◽

Cited By ~ 15

Author(s):

J.-M. Extra ◽

F. Cognetti ◽

S. Chan ◽

D. Maraninchi ◽

R. Snyder ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

First Line ◽

Her2 Positive ◽

First Line Therapy ◽

Line Therapy

Download Full-text